Philips Respironics, a unit of Royal Philips (NYSE: PHG, AEX: PHI) and a pioneer in science-based sleep solutions, today announces a significant advancement in sleep therapy with the commercial release of a first of its kind minimal contact nasal mask – Wisp. Designed to fit more than 98% of sleep apnea patients, Wisp brings distinctive styling and patented technology for a better overall mask experience that may improve patient compliance.
To view the Multimedia News Release, go to multivu.com/mnr/62230-philips-respironics-announces-advancement-in-sleep-therapy-with-wisp
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?